Literature DB >> 25218638

Bladder cancers arise from distinct urothelial sub-populations.

Jason Van Batavia1, Tammer Yamany1, Andrei Molotkov1, Hanbin Dan1, Mahesh Mansukhani2, Ekaterina Batourina1, Kerry Schneider1, Daniel Oyon1, Mark Dunlop1, Xue-Ru Wu3, Carlos Cordon-Cardo4, Cathy Mendelsohn1.   

Abstract

Bladder cancer is the sixth most common cancer in humans. This heterogeneous set of lesions including urothelial carcinoma (Uca) and squamous cell carcinoma (SCC) arise from the urothelium, a stratified epithelium composed of K5-expressing basal cells, intermediate cells and umbrella cells. Superficial Uca lesions are morphologically distinct and exhibit different clinical behaviours: carcinoma in situ (CIS) is a flat aggressive lesion, whereas papillary carcinomas are generally low-grade and non-invasive. Whether these distinct characteristics reflect different cell types of origin is unknown. Here we show using lineage tracing in a murine model of carcinogenesis that intermediate cells give rise primarily to papillary lesions, whereas K5-basal cells are likely progenitors of CIS, muscle-invasive lesions and SCC depending on the genetic background. Our results provide a cellular and genetic basis for the diversity in bladder cancer lesions and provide a possible explanation for their clinical and morphological differences.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218638     DOI: 10.1038/ncb3038

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  65 in total

1.  Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.

Authors:  Indira U Mysorekar; Matthew A Mulvey; Scott J Hultgren; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

Review 2.  Morphological diagnosis of urothelial neoplasms.

Authors:  R Montironi; R Mazzucchelli; M Scarpelli; A Lopez-Beltran; L Cheng
Journal:  J Clin Pathol       Date:  2007-06-01       Impact factor: 3.411

Review 3.  Cell biology and physiology of the uroepithelium.

Authors:  Puneet Khandelwal; Soman N Abraham; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 5.  Molecular pathways of urothelial development and bladder tumorigenesis.

Authors:  Mireia Castillo-Martin; Josep Domingo-Domenech; Orit Karni-Schmidt; Tulio Matos; Carlos Cordon-Cardo
Journal:  Urol Oncol       Date:  2010 Jul-Aug       Impact factor: 3.498

6.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

7.  Two molecular pathways to transitional cell carcinoma of the bladder.

Authors:  C H Spruck; P F Ohneseit; M Gonzalez-Zulueta; D Esrig; N Miyao; Y C Tsai; S P Lerner; C Schmütte; A S Yang; R Cote
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

8.  Incidence of squamous cell carcinoma in patients with long-term catheter drainage.

Authors:  J R Locke; D E Hill; Y Walzer
Journal:  J Urol       Date:  1985-06       Impact factor: 7.450

Review 9.  Malignant non-urothelial neoplasms of the urinary bladder: a review.

Authors:  Philipp Dahm; Jürgen E Gschwend
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

10.  A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium.

Authors:  Tian Huai Shen; Nataliya Gladoun; Mireia Castillo-Martin; Dennis Bonal; Josep Domingo-Domenech; Daniel Charytonowicz; Carlos Cordon-Cardo
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

View more
  82 in total

1.  New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies.

Authors:  Veronica Sciannameo; Angela Carta; Angelo d'Errico; Maria Teresa Giraudo; Francesca Fasanelli; Cecilia Arici; Milena Maule; Paolo Carnà; Paolo Destefanis; Luigi Rolle; Paolo Gontero; Giovanni Casetta; Andrea Zitella; Giuseppina Cucchiarale; Paolo Vineis; Stefano Porru; Carlotta Sacerdote; Fulvio Ricceri
Journal:  Int Arch Occup Environ Health       Date:  2018-11-30       Impact factor: 3.015

Review 2.  Sleeping beauty: awakening urothelium from its slumber.

Authors:  Zarine R Balsara; Xue Li
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-25

3.  Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.

Authors:  Mark O Kitchen; Richard T Bryan; Richard D Emes; John R Glossop; Christopher Luscombe; K K Cheng; Maurice P Zeegers; Nicholas D James; Adam J Devall; Charles A Mein; Lyndon Gommersall; Anthony A Fryer; William E Farrell
Journal:  Epigenetics       Date:  2016-03-01       Impact factor: 4.528

4.  ATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.

Authors:  Phillip L Palmbos; Lidong Wang; Huibin Yang; Yin Wang; Jacob Leflein; McKenzie L Ahmet; John E Wilkinson; Chandan Kumar-Sinha; Gina M Ney; Scott A Tomlins; Stephanie Daignault; Lakshmi P Kunju; Xue-Ru Wu; Yair Lotan; Monica Liebert; Mats E Ljungman; Diane M Simeone
Journal:  Cancer Res       Date:  2015-10-15       Impact factor: 12.701

5.  Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.

Authors:  Theodoros Tokas; Margaritis Avgeris; Christos Alamanis; Andreas Scorilas; Konstantinos G Stravodimos; Constantinos A Constantinides
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-17       Impact factor: 4.553

Review 6.  [The development of real-time multispectral imaging for the diagnostics of bladder cancer].

Authors:  C Bolenz; J Rother; S Meessen; B Grychtol; A Majlesara; N Gharabaghi; C Günes; M Ritter; N Deliolanis; M S Michel; M C Kriegmair
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

Review 7.  Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.

Authors:  Woonyoung Choi; Andrea Ochoa; David J McConkey; Mattias Aine; Mattias Höglund; William Y Kim; Francisco X Real; Anne E Kiltie; Ian Milsom; Lars Dyrskjøt; Seth P Lerner
Journal:  Eur Urol       Date:  2017-03-30       Impact factor: 20.096

8.  Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.

Authors:  Vasty Osei-Amponsa; Jenna M Buckwalter; Lauren Shuman; Zongyu Zheng; Hironobu Yamashita; Vonn Walter; Thomas Wildermuth; Justine Ellis-Mohl; Chang Liu; Joshua I Warrick; Lisa M Shantz; Robert P Feehan; Hikmat Al-Ahmadie; Cathy Mendelsohn; Jay D Raman; Klaus H Kaestner; Xue-Ru Wu; David J DeGraff
Journal:  Oncogene       Date:  2019-10-21       Impact factor: 9.867

Review 9.  Urothelial generation and regeneration in development, injury, and cancer.

Authors:  Caihong Wang; Whitney Trotter Ross; Indira U Mysorekar
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

Review 10.  Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2016-08-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.